Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis

Retina

Volumn 30, Issue 9, 2010, Pages 1530-1535

  Farvardin, Mohsen ^a   Afarid, Mehrdad ^a   Mehryar, Morsal ^a   Hosseini, Hamid ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

infliximab; intravitreal injection; posterior uveitis

Indexed keywords

INFLIXIMAB;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC NONINFECTIOUS UVEITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MALE; SCHOOL CHILD; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILD; CHRONIC DISEASE; EYE INFECTIONS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 77958586098     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181d3758a     Document Type: Article

References (18)

1. Demir T, Godekmerdan A, Balba M, Türkcüoglu P, Ilhan F, Demir N. The effect of infliximab, cyclosporine A and re-combinant IL-10 vitreous cytokine levels in experimental autoimmune uveitis. Indian J Ophthalmol 2006;54:241-245. (Pubitemid 44747209)
2. Valesini G, Innuccelli C, Marrocchi E, Pascoli L, Scalzi V, Di Franco M. Biological and clinical effect of anti TNF alpha treatment. Autoimmune Rev 2007;7:35-41.
3. Embert EC. Infliximab and TNF-alpha system. Am J Physiol Gastrointest Liver Physiol 2009;296:G612-G620.
4. Wong M, Ziring D, Korin Y, et al. TNF alpha blockade in human disease: mechanisms and future directions. Clin Immunol 2008;126:121-136.
5. Rodigues EB, Farah ME, Maia M, et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res 2009;28:117-144.
6. Lin J, Ziring D, Desai S, et al. TNF alpha blockade in human disease: an overview of efficacy and safety. Clin Immunol 2008;126:13-30. (Pubitemid 350266448)
7. Giansanti F, Ramazzotti M, Vannozzi L, et al. A pilot study on ocular safety of intravitreal infliximab in a rabbit model. Invest Ophthalmol Vis Sci 2008;49:1151-1156.
8. Hosseini H, Safaei A, Khalili M, et al. Intravitreal infliximab in experimental endotoxin-induced uveitis. Eur J Ophthalmol 2009;19:818-823.
9. Theodossiadis PG, Liarakos VS, Sfikakis PP, et al. Intra vitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol 2009;147:825-830.
10. Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 2007;27:399-413.
11. Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol 2007;125:895-900. (Pubitemid 47076425)
12. Ardon SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow up. Am J Ophthalmol 2007;144:844-849. (Pubitemid 350122362)
13. Hie S, Lightman S. Anti-TNF therapies in the management of acute and chronic uveitis. Cytokine 2006;33:231-237.
14. Richards JC, Tay-Kearney ML, Murray K, Manners P. In fliximab for juvenile idiopathic arthritis-associated uveitis. Clin Exp Ophthalmol 2005;33:461-468. (Pubitemid 44056400)
15. Abu EL-Asrar AM, Aboud EB, Aldibhi H, Al-Arfa JA. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet's disease. Int Ophthalmol 2005;26:83-92. (Pubitemid 44781873)
16. Wang Y, Gaudio PA. Infliximab therapy for 2 patients with Vogt-Koanagi-Harada syndrome. Ocul Immunol Infiamm 2008;16:167-171.
17. Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Course of macular edema in uveitis under medical treatment. Ocul Immunol Infiamm 2007;15:71-79. (Pubitemid 46897690)
18. Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaef-thimious S, Theodossiadis GP, Sfikakis PP. Inflix-imab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 2004;138:648-650 (Pubitemid 39420497)